Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in Southern Vietnam

Journal of Medical Microbiology

Volumn 66, Issue 1, 2017, Pages 46-53

  Anh, Nguyen Tuan ^a   Nga, Tran Vu Thieu ^b   Tuan, Huynh Minh ^c   Tuan, Nguyen Si ^d   Dao Minh, Y ^e   Van Vinh Chau, Nguyen ^b   Baker, Stephen ^b,f,g   Duong, Ho Huynh Thuy ^h  

^a UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c University Medical Center   (Viet Nam)

^d Thong Nhat Dong Nai General Hospital   (Viet Nam)

^e Dong Nai General Hospital   (Viet Nam)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF NATURAL SCIENCES   (Viet Nam)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; MLVA; Nosocomial infections; Vietnam

Indexed keywords

AMIKACIN; CARBAPENEM DERIVATIVE; CEFOPERAZONE PLUS SULBACTAM; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; SULTAMICILLIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; HOSPITAL; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TANDEM REPEAT; VIET NAM; ACINETOBACTER INFECTIONS; CLUSTER ANALYSIS; CROSS INFECTION; GENETICS; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; VERY ELDERLY; YOUNG ADULT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; IMIPENEM; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PREVALENCE; TANDEM REPEAT SEQUENCES; VIETNAM; YOUNG ADULT;

EID: 85014387911     PISSN: 00222615     EISSN: 14735644     Source Type: Journal    
DOI: 10.1099/jmm.0.000418     Document Type: Article

References (39)

1. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006;2:e7.
2. Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther 2013;11:395-409.
3. Evans BA, Amyes SG. OXA b-lactamases. Clin Microbiol Rev 2014; 27:241-263.
4. Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis 2010;51:79-84.
5. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010;65:233-238.
6. Poirel L, Leviandier C, Nordmann P. Prevalence and genetic analysis of lasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital. Antimicrob Agents Chemother 2006;50:3992-3997.
7. Brown S, Amyes S. OXA b-lactamases in Acinetobacter: the story so far. J Antimicrob hemother 2006;57:1-3.
8. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006;27:351-353.
9. Heritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect 2006;12:123-130.
10. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006;258:72-77.
11. Antunes LC, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 2014;71:292-301.
12. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013;11:297-308.
13. Nhu NT, Lan NP, Campbell JI, Parry CM, Thompson C et al. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J Med Microbiol 2014;63:1386-1394.
14. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987;138:569-578.
15. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME et al. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006;44:2974-2976.
16. La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006;44:827-832.
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement, CLSI document M100-S24. Wayne, PA: CLSI;2014.
18. Huang XZ, Cash DM, Chahine MA, Nikolich MP, Craft DW. Development and validation of a multiplex TaqMan real-time PCR for rapid detection of genes encoding four types of class D carbapenemase in Acinetobacter baumannii. J Med Microbiol 2012;61:1532-1537.
19. Segal H, Garny S, Elisha BG. Is ISABA-1 customized for Acinetobacter? FEMS Microbiol Lett 2005;243:425-429.
20. Pourcel C, Minandri F, Hauck Y, D’Arezzo S, Imperi F et al. Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol 2011;49:539-548.
21. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M et al. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics 2012;13:87.
22. Jolley KA, Maiden MC. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 2010; 11:595.
23. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-281.
24. Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y et al. Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 2005;11:22-29.
25. Liu Q, Li W, Du X, Li W, Zhong T et al. Risk and prognostic factors for multidrug-resistant Acinetobacter baumannii complex bacteremia: a retrospective study in a tertiary hospital of West China. PLoS One 2015;10:e0130701.
26. Trang NH, Nga TV, Campbell JI, Hiep NT, Farrar J et al. The characterization of ESBL genes in Escherichia coli and Klebsiella pneumoniae causing nosocomial infections in Vietnam. J Infect Dev Ctries 2013;7:922-928.
27. Van TD, Dinh QD, Vu PD, Nguyen TV, Pham CV et al. Antibiotic susceptibility and molecular epidemiology of Acinetobacter calcoaceticus-baumannii complex strains isolated from a referral hospital in northern Vietnam. J Glob Antimicrob Resist 2014;2:318-321.
28. Tada T, Miyoshi-Akiyama T, Kato Y, Ohmagari N, Takeshita N et al. Emergence of 16S rRNA methylase-producing Acinetobacter baumannii and Pseudomonas aeruginosa isolates in hospitals in Vietnam. BMC Infect Dis 2013;13:251.
29. Brigante G, Migliavacca R, Bramati S, Motta E, Nucleo E et al. Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmA. J Med Microbiol 2012;61:653-661.
30. OXA-23-like gene with an upstream ISAba1 in a Chinese hospital. Infect Genet Evol 2013;14:98-101.
31. Lee K, Kim MN, Choi TY, Cho SE, Lee S et al. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. Isolates from South Korea. Int J Antimicrob Agents 2009;33:520-524.
32. Lee HY, Huang CW, Chen CL, Wang YH, Chang CJ et al. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients. J Microbiol Immunol Infect 2015;48:588-596.
33. Lin YC, Hsia KC, Chen YC, Sheng WH, Chang SC et al. Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan. Antimicrob Agents Chemother 2010;54:2078-2084.
34. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G et al. OXA-58, a novel class D b-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005;49:202-208.
35. Maatallah M, Bakhrouf A, Habeeb MA, Turlej-Rogacka A, Iversen A et al. Four genotyping schemes for phylogenetic analysis of Pseudomonas aeruginosa: comparison of their congruence with multi-locus sequence typing. PLoS One 2013;8:e82069.
36. Tada T, Miyoshi-Akiyama T, Kato Y, Ohmagari N, Takeshita N et al. Emergence of 16S rRNA methylase-producing Acinetobacter baumannii and Pseudomonas aeruginosa isolates in hospitals in Vietnam. BMC Infect Dis 2013;13:251.
37. Kim DH, Choi JY, Kim HW, Kim SH, Chung DR et al. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother 2013;57:5239-5246.
38. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multi-resistant clones from an ancestral susceptible genetic pool. PLoS One 2010;5:e10034.
39. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 2013;41:11-19.